- Home
- ANEB vs RDI Comparison
ANEB vs RDI Comparison
Compare ANEB & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- RDI
- Stock Information
- Founded
- ANEB 2020
- RDI 1937
- Country
- ANEB United States
- RDI United States
- Employees
- ANEB N/A
- RDI N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- RDI Movies/Entertainment
- Sector
- ANEB Health Care
- RDI Consumer Discretionary
- Exchange
- ANEB Nasdaq
- RDI Nasdaq
- Market Cap
- ANEB 36.7M
- RDI 30.1M
- IPO Year
- ANEB 2021
- RDI N/A
- Fundamental
- Price
- ANEB $0.98
- RDI $1.25
- Analyst Decision
- ANEB Buy
- RDI Hold
- Analyst Count
- ANEB 1
- RDI 1
- Target Price
- ANEB $8.00
- RDI $2.40
- AVG Volume (30 Days)
- ANEB 37.4K
- RDI 61.2K
- Earning Date
- ANEB 05-14-2025
- RDI 05-14-2025
- Dividend Yield
- ANEB N/A
- RDI N/A
- EPS Growth
- ANEB N/A
- RDI N/A
- EPS
- ANEB N/A
- RDI N/A
- Revenue
- ANEB N/A
- RDI $210,527,000.00
- Revenue This Year
- ANEB N/A
- RDI $11.97
- Revenue Next Year
- ANEB N/A
- RDI $6.40
- P/E Ratio
- ANEB N/A
- RDI N/A
- Revenue Growth
- ANEB N/A
- RDI N/A
- 52 Week Low
- ANEB $0.80
- RDI $1.17
- 52 Week High
- ANEB $3.30
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- ANEB 35.89
- RDI 42.49
- Support Level
- ANEB $0.94
- RDI $1.18
- Resistance Level
- ANEB $1.12
- RDI $1.29
- Average True Range (ATR)
- ANEB 0.14
- RDI 0.10
- MACD
- ANEB -0.03
- RDI -0.01
- Stochastic Oscillator
- ANEB 11.17
- RDI 18.75
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.